Published in Cancer Weekly, June 19th, 2012
The news correspondents obtained a quote from the research by the authors from Research Institute, "To date, no characterized molecular marker has been validated for the diagnosis of EC. In addition, new methods for prognosis and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.